Fisher & Paykel Healthcare Corporation Limited · NZX:FPH
Fisher & Paykel Healthcare — Shareholder Meeting (2020)
25 slides from Fisher & Paykel Healthcare's shareholder meeting presentation, 2020
Slide 1: Annual Shareholders' Meeting 2020
Annual Shareholders’ Meeting 2020 HEALTHEARE
Slide 2: Your Board
Your Board Tony Carter Lewis Gradon Michael Daniell Pip Greenwood A Geraldine McBride Neville Mitchell Donal O’Dwyer Scott St John Fisher &Paykel HEALTHCARE
Slide 3: Agenda
Agenda * Chair’s Address * Board Subcommittee Updates * Managing Director and Chief Executive Officer’s Review * Financial Statements * Resolutions * Voting * General Questions Fisher &Paykel HEALTHCARE
Slide 4: FY2020 Financial Highlights
FY2020 Financial Highlights Operating $1.26B tA % ce: Revenue Net Profit § $287.3m 137% After Tax Dividend 27.5 cents 118% HEALTHCARE
Slide 5: FY2020 Revenue by Product Group
FY2020 Revenue by Product Group Homecare 56% OF OPERATING REVENUE Hospital 63% OF OPERATING REVENUE Distributed & Other <1% OF OPERATING REVENUE Fisheré.Paykel HEALTHCARE
Slide 6: COVID-19 Patient - Brussels, Belgium
COVID-19 Patient - Brussels, Belgium Fisher &Paykel HEALTHCARE
Slide 7: Hospital Product Group
Hospital Product Group FY20 Result Revenue $801.3M FY20 Revenue Growth t fe} fe} n 436.3 NZ$ 725% cos FY16 FY17 FY18 FY19 FY20 Fisher &Paykel HEALTHCARE
Slide 8: Evora compact nasal mask
Homecare —_— F&P Evora™ compact nasal mask Fisher & Paykel HEALTHCARE
Slide 9: Homecare Product Group
Homecare Product Group FY20 Result Revenue $457.3M FY20 Revenue Growth NZ$ 19% Constant Currency t A% 6% cAGR 365.8 421.4 457.3 FY16 FY17 FY18 FY19 FY20 Fisher &Paykel HEALTHCARE
Slide 10: Gross and Operating Margins
Gross and Operating Margins Gross Margin Operating (EBIT) Margin 70% a — 30% — — ee 60% 25% 50% 20% 40% 15% 30% 20% 10% 10% 5% 0% 0% 2015 2016 §=2017- «2018 ~= 2019-2020 2015 2016 ~«2017.-—«2018~=«2019 «2020 = = Long Term Gross Margin target - 65% = = Long Term Operating Margin target - 30% Fisher &
Slide 11: Research and development - $118.5 million investment
Research and development - $118.5 million investment Fisher & Paykel HEALTHCARE
Slide 12: Rapid response team planning before COVID-19 arrived in New Zealand
Rapid response team planning before COVID-19 arrived in New Zealand Fisher &Paykel HEALTHCARE
Slide 13: FY21 Trading Update
FY21 Trading Update First four months of FY21 * Strong demand for the company’s Hospital respiratory care products * Hospital product group revenue +91% - Hardware revenue +390% cc - Consumables revenue +48% cc * Homecare product group revenue +5% cc Fisher &Paykel HEALTHCARE
Slide 14: FY21 Guide
FY21 Guide Assumptions for FY21 Guide « Respiratory hospitalisations return to normal by end of calendar year * Countries continue to build respiratory care infrastructure ¢ Trend toward nasal high flow continues for COVID and non-COVID patients « OSA diagnosis rates are reduced for the year * Costs
Slide 15: Financial Statements
Financial Statements * Opportunity for shareholders to ask any questions specifically on the financial statements, the auditor’s report or the company’s 2020 annual report. ¢ There will be an opportunity to ask any general questions once all items on the agenda have been considered. Fisheré.Paykel H
Slide 16: Resolutions
Resolutions 1. Re-election of Pip Greenwood as Director 2. Re-election of Geraldine McBride as Director 3. Auditor’s Remuneration 4. Directors’ Remuneration 5. Issue of Performance Share Rights 6. Issue of Options 7. Long Term Variable Remuneration Issue to North American Employees Fisher &Paykel HE
Slide 17: How to Vote Online
How to Vote Online LIVE Virtual Meeting Voting box Question box 0800 200 220 cael Notice of m Annual report Fisher &Paykel HEALTHCARE
Slide 18: Resolution 1: Re-election of Pip Greenwood
Resolution 1: Re-election of Pip Greenwood That Pip Greenwood, who retires by rotation and, being eligible, offers herself for re-election, be re-elected as a director of the Company. Click “Submit Vote” to lodge your vote. Need help? Call the Link Market Services helpline 0800 200 220 Fisher &Payke
Slide 19: Resolution 2: Re-election of Geraldine McBride
Resolution 2: Re-election of Geraldine McBride That Geraldine McBride, who retires by rotation and, being eligible, offers herself for re-election, be re-elected as a director of the Company. Click “Submit Vote” to lodge your vote. Need help? Call the Link Market Services helpline O800 200 220 Fishe
Slide 20: Resolution 3: Auditor's Remuneration
Resolution 3: Auditor’s Remuneration That the Directors be authorised to fix the fees and expenses of PwC as the Company’s auditor. Click “Submit Vote” to lodge your vote. Need help? Call the Link Market Services helpline 0800 200 220 Fisher &Paykel HEALTHCARE
Slide 21: Resolution 4: Directors' Remuneration
Resolution 4: Directors’ Remuneration That the maximum aggregate annual remuneration payable to non-executive Directors be increased by NZ$405,000 from NZ$1,050,000 to NZ$1,455,000 (plus GST as appropriate). Click “Submit Vote” to lodge your vote. Need help? Call the Link Market Services helpline O8
Slide 22: Resolution 5: Issue of Performance Share Rights
Resolution 5: Issue of Performance Share Rights That approval be given for the issue of up to 60,000 performance share rights under the Fisher & Paykel Healthcare Performance Share Rights Plan to Lewis Gradon, Managing Director and Chief Executive Officer of the Company. Click “Submit Vote” to lodge
Slide 23: Resolution 6: Issue of Options
Resolution 6: Issue of Options That approval be given for the issue of up to 190,000 options under the Fisher & Paykel Healthcare 2019 Share Option Plan to Lewis Gradon, Managing Director and Chief Executive Officer of the Company. Click “Submit Vote” to lodge your vote. Need help? Call the Link Mar
Slide 24: Resolution 7: North American Plan Rules
That the 2019 Performance Share Rights Plan Rules – North American Plan and the 2019 Share Option Plan Rules - North American Plan be approved.
Slide 25: This concludes the 2020 Annual Shareholders' Meeting
This concludes the 2020 Annual Shareholders’ Meeting. Thank you for attending.
Fisher & Paykel Healthcare — Shareholder Meeting (2020) on 6ix